TIAA CREF INVESTMENT MANAGEMENT LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 120 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$4,155,000
+1.2%
510,408
+0.4%
0.00%0.0%
Q4 2018$4,104,000
-46.8%
508,508
-49.7%
0.00%0.0%
Q3 2018$7,708,000
+149.9%
1,010,212
+87.7%
0.00%
+50.0%
Q2 2018$3,084,000
+17.9%
538,295
-1.8%
0.00%0.0%
Q1 2018$2,615,000
-3.1%
548,146
-0.2%
0.00%0.0%
Q4 2017$2,698,000
+2.6%
549,401
+9.5%
0.00%0.0%
Q3 2017$2,630,000
+0.9%
501,930
+7.0%
0.00%0.0%
Q2 2017$2,607,000
-11.9%
468,882
+33.2%
0.00%0.0%
Q1 2017$2,958,000
+29.8%
352,100
-2.2%
0.00%0.0%
Q4 2016$2,279,000
+34.1%
360,022
-6.6%
0.00%
+100.0%
Q3 2016$1,699,000
+54.2%
385,339
-0.7%
0.00%0.0%
Q2 2016$1,102,000
+19.1%
388,150
+18.7%
0.00%0.0%
Q1 2016$925,000
-72.6%
326,8730.0%0.00%
-66.7%
Q4 2015$3,373,000
-12.4%
326,873
-3.2%
0.00%0.0%
Q3 2015$3,850,000
-26.5%
337,717
-3.7%
0.00%
-25.0%
Q2 2015$5,236,000
+64.2%
350,731
-0.7%
0.00%
+100.0%
Q1 2015$3,188,000
-25.6%
353,038
+0.1%
0.00%
-33.3%
Q4 2014$4,287,000
+19.1%
352,554
-4.2%
0.00%0.0%
Q3 2014$3,601,000
-19.6%
368,154
+4.8%
0.00%0.0%
Q2 2014$4,478,000
+55875.0%
351,228
+7088.5%
0.00%
Q2 2013$8,0004,8860.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders